Acquiring Company
Icon Group
Acquired Company
Pharmaxo
Brisbane
WiltshireHealth CareBiotechnologyHealth CareMedicalDescription
Icon Group, a leading cancer care provider, has strategically acquired Pharmaxo, a UK-based provider of pharmacy aseptic compounding services and homecare pharmacy services, in a strategic partnership. This acquisition aims to enhance the specialized pharmacy services offered by Pharmaxo and further strengthen Icon Group's commitment to patient-centric care and innovation.
Quick answer
Icon Group is acquiring Pharmaxo, announced July 10, 2024. Icon Group is based in Brisbane, Queensland, Australia.
- How much did Icon Group pay for Pharmaxo?
- The deal value was not disclosed.
- What does Icon Group do?
- Across Australia, New Zealand and Asia we’re dedicated to delivering the best care possible, to as many people as possible, as close to home as possible.
- Where are Icon Group and Pharmaxo based?
- Icon Group is based in Brisbane, Queensland, Australia. Pharmaxo is based in Wiltshire, England, United Kingdom.
- Who are the decision-makers at Icon Group?
- Fundz holds 1 contact at Icon Group. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Health Care
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- KARL STORZ completes acquisition of Asensus Surgical, Inc. to strengthen its position in robotic and digital surgical market (August 22, 2024)
- GE HealthCare to acquire clinical artificial intelligence business from Intelligent Ultrasound Group PLC (July 18, 2024)
- AA Medical completes acquisition of Surgical Product Solutions, forming strategic partnership (July 11, 2024)
- ADVI Health completes acquisition of Partnership for Health Analytic Research to enhance Strategic Analytics, Value and Economics capabilities (August 23, 2024)
- Trudell Medical Limited to acquire Vyaire Medical RDx, expanding into respiratory diagnostics (August 22, 2024)
- Leapcure Acquires Honeybee Trials: Enhancing Patient Engagement and Research Site Solutions (August 13, 2024)
Who to call at Icon Group, and when
When Icon Group changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Icon Group raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Icon Group, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Icon Group. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Icon Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Pharmaxo?
Pharmaxo was acquired by Icon Group, based in Brisbane. The deal was reported on July 10, 2024. Across Australia, New Zealand and Asia we’re dedicated to delivering the best care possible, to as many people as possible, as close to home as possible. Icon Group is privately held and operates in Health Care.
When did Icon Group acquire Pharmaxo?
Icon Group's acquisition of Pharmaxo was reported on July 10, 2024. Icon Group, a leading cancer care provider, has strategically acquired Pharmaxo, a UK-based provider of pharmacy aseptic compounding services and homecare pharmacy services, in a strategic partnership. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Pharmaxo do?
Pharmaxo is a UK-based provider of pharmacy aseptic compounding services and homecare pharmacy services. It is privately held, operating in Biotechnology, and is based in Wiltshire.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.